GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) » Definitions » Days Payable

Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Days Payable : 1,658.96 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Suzhou Zelgen Biopharmaceuticals Co Days Payable?

Suzhou Zelgen Biopharmaceuticals Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥130.0 Mil. Suzhou Zelgen Biopharmaceuticals Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥7.1 Mil. Hence, Suzhou Zelgen Biopharmaceuticals Co's Days Payable for the three months ended in Mar. 2024 was 1,658.96.

The historical rank and industry rank for Suzhou Zelgen Biopharmaceuticals Co's Days Payable or its related term are showing as below:

SHSE:688266' s Days Payable Range Over the Past 10 Years
Min: 1545.55   Med: 13108.53   Max: 775559.82
Current: 1545.55

During the past 8 years, Suzhou Zelgen Biopharmaceuticals Co's highest Days Payable was 775559.82. The lowest was 1545.55. And the median was 13108.53.

SHSE:688266's Days Payable is ranked better than
87.38% of 721 companies
in the Biotechnology industry
Industry Median: 148.78 vs SHSE:688266: 1545.55

Suzhou Zelgen Biopharmaceuticals Co's Days Payable increased from Mar. 2023 (1,622.90) to Mar. 2024 (1,658.96). It may suggest that Suzhou Zelgen Biopharmaceuticals Co delayed paying its suppliers.


Suzhou Zelgen Biopharmaceuticals Co Days Payable Historical Data

The historical data trend for Suzhou Zelgen Biopharmaceuticals Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Zelgen Biopharmaceuticals Co Days Payable Chart

Suzhou Zelgen Biopharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial - 775,559.82 5,331.71 1,882.92 1,808.36

Suzhou Zelgen Biopharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,622.90 1,184.73 2,178.58 1,500.78 1,658.96

Competitive Comparison of Suzhou Zelgen Biopharmaceuticals Co's Days Payable

For the Biotechnology subindustry, Suzhou Zelgen Biopharmaceuticals Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Zelgen Biopharmaceuticals Co's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Zelgen Biopharmaceuticals Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Suzhou Zelgen Biopharmaceuticals Co's Days Payable falls into.



Suzhou Zelgen Biopharmaceuticals Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Suzhou Zelgen Biopharmaceuticals Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (151.721 + 137.735) / 2 ) / 29.212*365
=144.728 / 29.212*365
=1,808.36

Suzhou Zelgen Biopharmaceuticals Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (137.735 + 122.208) / 2 ) / 7.149*365 / 4
=129.9715 / 7.149*365 / 4
=1,658.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzhou Zelgen Biopharmaceuticals Co Days Payable Related Terms

Thank you for viewing the detailed overview of Suzhou Zelgen Biopharmaceuticals Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Business Description

Traded in Other Exchanges
N/A
Address
No.209 Chenfeng Road, Yushan Town, Jiangsu Province, Kunshan, CHN
Suzhou Zelgen Biopharmaceuticals Co Ltd is engaged in research and development of new chemical and biological drugs for various therapeutic areas, including tumors, bleeding and blood diseases, and hepatobiliary diseases.
Executives
Zhang Bin Core technical personnel
Huang Gang senior management
Lv Bin Hua Directors, senior managers, core technical personn
Lu Hui Ping Directors, senior managers
Gao Qing Ping senior management
Wu Ji Sheng Directors, senior managers, core technical personn
Zhang Jun Li senior management
Wu Li Qing Core technical personnel
Core technical personnel
Sheng Ze Lin Directors, senior managers, core technical personn

Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Headlines

No Headlines